May 25, 2023CorporateTerumo Blood and Cell Technologies Optimizing Cell Therapy Production Through Industry’s First Apheresis Training for Cell Therapy ManufacturersTerumo Blood and Cell Technologies presents data on collection efficiency process with Spectra Optia® Apheresis System at major conferences
May 15, 2023CorporateTerumo to Construct a New Manufacturing Facility at its Kofu Factory for the Medical Care Solutions Company52.2 Billion JPY Capital Investment to Strengthen the Production Capability to Meet the Growing Global Demands
Top Management Message Message from top management to shareholders and investors. /investors/management/message Corporate Governance /about/governance Compliance /about/compliance Leadership Team /about/leadership Business Risks Major risks that may affect the business performance and financial position of the Terumo Group are described. /investors/management/risk IR Policy /investors/management/ir_policy Disclaimer /investors/disclaimer